Scientists have identified a potential target for a new class of drugs that could effectively treat psychiatric disorders, ...
Rapamycin, competing with other rapalogs, activates TRPM8 via directly binding to a novel binding site, which results in providing new insights into the mechanisms of TRPM8 activation.